Onterris, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data Onterris, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2018	FY2020	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	189	234	328	546	544	624	696	831
Cost of revenue	135	164	215	369	352	384	418	496
Gross profit	54.1	69.9	113	177	193	240	278	334
Selling, general and administrative	41	49.7	85.5	118	176	223	262	271
Operating income	-10.6	-8.95	-23	-9.46	-28	-28.4	-36.7	11.7
Other non-operating income	-10.8	-17.7	-34.1	-14.2	-1.56	-3.42	-17.6	-0.5
Pre-tax income	-21.5	-26.7	-57.1	-23.6	-29.6	-31.8	-54.3	11.2
Income tax	-4.97	-3.12	0.85	1.71	2.25	-0.98	8	12.1
Net income	-16.5	-23.6	-57.9	-25.3	-31.8	-30.9	-62.3	-0.84
EBITDA	13.3	18.8	14.3	35.4	19.5	17.4	16	62.6
EPS, basic	-2.79	-4.91	-6.48	-1.56	-1.62	-1.57	-2.22	-0.14
EPS, diluted	-2.79	-4.91	-6.48	-1.56	-1.62	-1.57	-2.22	-0.14
Shares, basic (weighted)	7.53	8.79	16.5	26.7	29.7	30.1	33.1	35.1
Shares, diluted (weighted)	7.53	8.79	16.5	26.7	29.7	30.1	33.1	35.1

Balance sheet

	FY2018	FY2020	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents		6.41	34.4	146	89.8	23.2	12.9	11.2
Receivables		45.9	54.1	98.5	94.7	112	159	155
Other current assets		5.62	6.71	7.96	10.3	13.7	14.1	15
Total current assets		73.2	134	294	248	201	238	240
Property, plant and equipment		27	34.4	31.5	36	56.8	63.8	63.9
Lease right-of-use assets				23.5	26	32.3	39.8	36.6
Goodwill		127	275	312	324	364	468	467
Intangible assets		103	155	161	142	141	153	126
Other non-current assets		1.96	4.54	2.3	6.09	8.27	8.64	9.73
Total assets		332	603	833	792	817	990	981
Accounts payable		15	15.5	24.2	25.4	31.1	33.4	34.8
Accrued liabilities		10.7	11.5	14.9	14.8	16.1	16.2	18.4
Deferred revenue		3.31	6.11	27.9	18.5	8.13	9.3	15
Short-term debt		7.14	5.58	10.9	12	14.2	17.9	11.2
Total current liabilities		73.3	112	148	111	126	159	168
Long-term debt		145	170	162	152	149	205	277
Lease liabilities				16.9	19.4	25	30.9	28.2
Other non-current liabilities		0.38	2.52	0.1	0.01	6.57	5.55	7.09
Total liabilities		229	313	364	326	343	451	530
Total debt		152	180	175	166	165	224	288
Paid-in capital		38.2	259	464	493	532	721	728
Retained earnings		-64.4	-122	-148	-179	-210	-273	-274
Treasury stock								0
Other comprehensive income		-0.04	0.07	0.04	0.01	-0.22	-2.13	-3.24
Shareholders' equity	6.9	-26.3	137	317	313	321	446	451
Total equity	6.9	-26.3	137	317	313	321	446	451
Total liabilities and equity		332	603	833	792	817	990	981
Shares outstanding		8.37	24.9	29.6	29.7	30.2	34.3	35.9

Cash flow statement

	FY2018	FY2020	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-16.5	-23.6	-57.9	-25.3	-31.8	-30.9	-62.3	-0.84
Depreciation and amortization	23.9	27.7	37.3	44.8	47.5	45.8	52.8	50.9
Stock-based compensation	5.79	4.35	4.85	10.3	43.3	47.3	64.7	42.7
Deferred income tax	-4.97	-3.12	0.85	1.71	2.25	-0.98	4.29	9.9
Change in receivables	-10	-6.59	-19.2	-36.2	4.39	-2.92	-42	-10.1
Change in payables	-2.2	6.09	0.6	24	-9.88	-8.91	3.8	8.35
Cash from operations	-2.85	17	1.85	37.6	20.6	56	22.2	107
Capital expenditures	-3.77	-4.69	-7.76	-6.89	-9.58	-29.6	-21.3	-16.3
Acquisitions	-45.8	-81.4	-174	-55.7	-28.6	-66.2	-113
Cash from investing	-50.3	-87	-180	-71.6	-38.7	-102	-138	-15.8
Stock issued	0.03	1.51	0.41	7.24	1.64	4.69	122	1.07
Share buybacks	-2.72
Dividends paid			-6.97	-16.4	-16.4	-16.4	-11.1	-4.15
Cash from financing	50.9	74.5	206	146	-38.8	-20.1	106	-93.1
Net change in cash	-2.28	4.51	28	112	-56.8	-65.7	-9.81	-1.49
Free cash flow	-6.62	12.4	-5.91	30.7	11.1	26.4	0.9	91.2
Interest paid	7.92	5.89	11.9	5.01	6.51	8.06	14.8	17.9
Income taxes paid	0.6	1.21	0.17	0.41	0.79	1	4.19	5.51

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $14.00 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	40.4%	Gross profit / revenue.
Operating margin	1.0%	Operating income / revenue.
EBITDA margin	7.5%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-0.0%	Pre-tax income / revenue.
Net margin	-1.4%	Net income / revenue.
FCF margin	6.7%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	9.6%	Cash from operations / revenue.
Return on equity (ROE)	-2.6%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-1.2%	Net income / average total assets.
Return on invested capital (ROIC)	0.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	33.0%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	4.8%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.9%	Capital expenditures / revenue.
D&A / revenue	6.5%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	19.3%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	15.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	20.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	20.2%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	20.2%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	24.3%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	290.5%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	47.6%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	34.4%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	383.4%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	73.3%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	125.3%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	10,006.0%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	102.0%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y	1.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	12.9%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	26.9%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-0.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	7.4%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	10.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	6.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	5.8%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	16.3%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.00x	Current assets / current liabilities.
Quick ratio	1.22x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.11x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.81x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	36.1%	Total debt / total assets.
Liabilities / assets	55.5%	Total liabilities / total assets.
Net debt	$336.3M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	5.80x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$119.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	59.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$149.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.80x	Revenue / average total assets.
Fixed asset turnover	11.7x	Revenue / average property, plant and equipment.
Receivables turnover	5.81x	Revenue / average receivables.
Days sales outstanding	63 days	365 x average receivables / revenue.
Days payables	17 days	365 x average accounts payable / cost of revenue.
Capex / operating cash flow	30.2%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.29	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$19.98	Revenue / diluted weighted shares.
FCF per share	$1.35	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1.93	Cash from operations / diluted weighted shares.
Book value per share	$12.26	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$4.25	Tangible book value / shares outstanding.
Cash per share	$0.36	(Cash + short-term investments) / shares outstanding.
Dividends / FCF	2.7%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$491.6M	Share price x shares outstanding.
Enterprise value	$828.0M	Market cap + total debt - cash - short-term investments.
P/S	0.64x	Market cap / revenue.
P/B	1.14x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	9.44x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	6.59x	Market cap / cash from operations, when positive.
EV/Sales	1.07x	Enterprise value / revenue.
EV/EBIT	107x	Enterprise value / operating income, when both are positive.
EV/EBITDA	14.3x	Enterprise value / EBITDA, when both are positive.
EV/FCF	15.9x	Enterprise value / free cash flow, when both are positive.
FCF yield	10.6%	Free cash flow / market cap.
Earnings yield	-2.3%	Net income / market cap (the inverse of P/E).
Dividend yield	0.3%	Dividends paid over the period / market cap.
Shareholder yield	0.3%	(Dividends paid + share buybacks) / market cap.

What was Onterris, Inc.'s revenue in fiscal 2025?

Onterris, Inc. reported revenue of $830.5M for fiscal 2025, 19.3% higher than the year before.

Was Onterris, Inc. profitable in fiscal 2025?

No. It reported a net loss of $843.0K.

How much free cash flow did Onterris, Inc. generate in fiscal 2025?

Cash from operations of $107.5M minus capital expenditures of $16.3M left free cash flow of $91.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Onterris, Inc.